Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Aesica recruits East Coast Business Development Manager to spearhead US expansion
Aesica recruits East Coast Business Development Manager to spearhead US expansion
Also hires a Director of Finance and Administration to support the expanding US office
ShangPharma appoints Arthur Taveras as President and CSO
ShangPharma appoints Arthur Taveras as President and CSO
Taveras brings the experience of a 24-year career to the Chinese contract research organisation
Mylan appoints Jacek Glinka as President of its European Business
Mylan appoints Jacek Glinka as President of its European Business
The former Chief Executive of the Polpharma Group will take up the role on 2 December
Astellas adds to global development team
Astellas adds to global development team
Promotes Mark Weinberg to VP Global Clinical Science and appoints Robin McGarry as Head of Global Medical Safety
Former Chairman and CEO of Bayer France joins Neovacs
Former Chairman and CEO of Bayer France joins Neovacs
Miguel Sieler replaces Guy-Charles Fanneau De La Horie
Simcere Pharmaceutical Group appoints Chief Scientific Officer
Simcere Pharmaceutical Group appoints Chief Scientific Officer
Dr Zang Jingwu to lead research and development team
Cardio3 BioSciences strengthens management team
Cardio3 BioSciences strengthens management team
Hires Dr Gaëtane Metz as Chief Operating Officer
Results Healthcare appoints Nick Hyde as Managing Director
Results Healthcare appoints Nick Hyde as Managing Director
Life sciences industry veteran has been in the industry for more than 25 years
Catalent Applied Drug Delivery Institute adds Advisory Board member
Catalent Applied Drug Delivery Institute adds Advisory Board member
Professor Claus-Michael Lehr has spent more than 15 years in drug delivery research
Glenn Killingworth joins PCI as VP of Business Development
Glenn Killingworth joins PCI as VP of Business Development
Will drive business growth at the Newburyport, MA, US-based firm
Daiichi Sankyo makes two executive appointments
Daiichi Sankyo makes two executive appointments
Glenn Gormley and Greg Barrett are promoted at the US business
Actavis plc names Board of Directors
Actavis plc names Board of Directors
Following the finalisation of the takeover of Warner Chilcott
Nick Haggar of Sandoz to become new EGA President
Nick Haggar of Sandoz to become new EGA President
Takes up the role on 8 October
Results Healthcare announces further expansion into US market
Results Healthcare announces further expansion into US market
Executive Director Hemavli Bali relocates to New York
Olivier Brandicourt to become new CEO of Bayer HealthCare
Olivier Brandicourt to become new CEO of Bayer HealthCare
Former Pfizer executive joins the German pharmaceutical firm
Merck reorganises management team at Merck Serono biopharmaceutical division
Merck reorganises management team at Merck Serono biopharmaceutical division
Belén Garijo, currently Chief Operating Officer, has been appointed President and Chief Executive
Previous
1
…
137
138
139
140
(current)
141
142
143
…
216
Next
Trending Articles
Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform
Qinecsa will help deliver a continent-wide medicines safety platform connecting safety data across Africa
Gerresheimer names new Chairman of the Supervisory Board
This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe
Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
Chiesi appoints David Khougazian as Group chief executive officer
David Khougazian to lead the next phase of innovation-driven growth
CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer
Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all